Via Scoop.it - Pulmonary Fibrosis News
Pirfenidone: Extent of added benefit assessedEurekAlert (press release)Pirfenidone inhibits the development of inflammation and scarring (fibrosis) in pulmonary tissue and has been approved for the treatment of mild to moderate idiopathic pulmonary…
Via eurekalert.org